Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.
Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.
复制标题
DOI:
10.1371/journal.pone.0094949
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Hanekom WA
中科院分区:
文献类型:
--
作者:
Day CL;Moshi ND;Abrahams DA;van Rooyen M;O'rie T;de Kock M;Hanekom WA
CD8 T cells play a critical role in control of chronic viral infections; however, the role of these cells in containing persistent bacterial infections, such as those caused by Mycobacterium tuberculosis (Mtb), is less clear. We assessed the phenotype and functional capacity of CD8 T cells specific for the immunodominant Mtb antigens CFP-10 and ESAT-6, in patients with pulmonary tuberculosis (TB) disease, before and after treatment, and in healthy persons with latent Mtb infection (LTBI). In patients with TB disease, CFP-10/ESAT-6-specific IFN-γ+ CD8 T cells had an activated, pro-apoptotic phenotype, with lower Bcl-2 and CD127 expression, and higher Ki67, CD57, and CD95 expression, than in LTBI. When CFP-10/ESAT-6-specific IFN-γ+ CD8 T cells were detectable, expression of distinct combinations of these markers was highly sensitive and specific for differentiating TB disease from LTBI. Successful treatment of disease resulted in changes of these markers, but not in restoration of CFP-10/ESAT-6-specific CD8 or CD4 memory T cell proliferative capacity. These data suggest that high mycobacterial load in active TB disease is associated with activated, short-lived CFP-10/ESAT-6-specific CD8 T cells with impaired functional capacity that is not restored following treatment. By contrast, LTBI is associated with preservation of long-lived CFP-10/ESAT-6-specific memory CD8 T cells that maintain high Bcl-2 expression and which may readily proliferate.
登录
查看更多内容
影响因子:
82.9
作者:
Harari A;Rozot V;Bellutti Enders F;Perreau M;Stalder JM;Nicod LP;Cavassini M;Calandra T;Blanchet CL;Jaton K;Faouzi M;Day CL;Hanekom WA;Bart PA;Pantaleo G
通讯作者:
Pantaleo G
影响因子:
3.7
作者:
Caccamo N;Guggino G;Meraviglia S;Gelsomino G;Di Carlo P;Titone L;Bocchino M;Galati D;Matarese A;Nouta J;Klein MR;Salerno A;Sanduzzi A;Dieli F;Ottenhoff TH
通讯作者:
Ottenhoff TH
DOI:
10.1084/jem.175.4.1111
发表时间:
1992-04-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Chan J;Xing Y;Magliozzo RS;Bloom BR
通讯作者:
Bloom BR
DOI:
10.4049/jimmunol.1101122
发表时间:
2011-09-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Day CL;Abrahams DA;Lerumo L;Janse van Rensburg E;Stone L;O'rie T;Pienaar B;de Kock M;Kaplan G;Mahomed H;Dheda K;Hanekom WA
通讯作者:
Hanekom WA
影响因子:
4.4
作者:
Caccamo, Nadia;Meraviglia, Serena;Salerno, Alfredo
通讯作者:
Salerno, Alfredo